Does a Real Anti-Aging Pill Already Exist?

food-and-drug-administration,national-institutes-of-health,us-immigration-and-customs-enforcement

NOVN:SW,0835639D:US,GSK:LN,0177134Z:NL,NYT:US,1023202D:US,GOOGL:US,PFE:US

industrials,science,cancer,emerging-markets,consumer-discretionary

Cancer

Science

Montreal

Brooklyn

Canada

Public Health

Pakistan

Drugs

Chicago

St. Petersburg

Women

Christmas

Australia

New Zealand

Startups

Media

Basel

Switzerland

San Antonio

Europe

Inclusion

Markets

Equality

Great Britain

Industrials

Healthcare

ESG Concerns

Emerging Markets

Asia

Africa

Americas

Futures Markets

Consumer Discretionary

Gender Equality

Emerging Markets Economics

United States

Nigeria

Commodity Futures

Media and Entertainment

Technology

United Kingdom

Inside Novartis’s push to produce the first legitimate anti-aging drug

Bloomberg subscribers can save articles and view them from any device.

Upgrade to an unlimited subscription to save articles and view them from anywhere.

Bloomberg subscribers can send up to {count} articles a month to anyone to read for free, including non-subscribers.

Upgrade your subscription to send up to {count} articles a month to anyone to read for free, including non-subscribers.

Copy article link

Hello,<p>A Bloomberg.com subscriber thought you might want to read this story. To read it, all you need to do is click on the link – no subscription necessary. (Please note the link will only be valid for {days} days.)

Email article link

Please try again. If the problem persists, please contact customer support.

Something went wrong

We've doubled your gift articles this month. Share up to {count} articles with friends, family or colleagues.

As a subscriber, you can gift up to {count} articles this month. The recipient can read the full article for free – no subscription necessary.

As a subscriber, you can gift up to {count} articles each month. The recipient can read the full article for free – no subscription necessary.